India and UK likely to approve AstraZeneca vaccine use

“India and UK likely to approve AstraZeneca vaccine use”
Expert meeting scheduled soon after UK approval… Inoculation promotion starting next month
18,000 new confirmed cases… Lowest in 5 months since early July

(New Delhi = Yonhap News) Correspondent Kim Young-hyun = The Indian government plans to approve the emergency use of a novel coronavirus infection (Corona 19) vaccine jointly developed by AstraZeneca and Oxford University following the UK.
An official from Indian health authorities said, “As soon as the UK drug regulatory authority approves the AstraZeneca vaccine, we will hold a meeting of the Expert Committee of the Central Pharmaceutical Standards Administration (CDSCO) and thoroughly review the safety and immunogenicity data of this vaccine. Indian media including PTI News reported on the 27th.
The official added that the AstraZeneca vaccine is expected to be approved for emergency use in India and distributed accordingly.
To date, no country has approved the emergency use of the AstraZeneca vaccine. The British newspaper Telegraph reported on the 26th that the first approval could be dropped in the UK as early as the 27th.
Currently, six vaccines are in clinical trials in India, and three other vaccines are known to be in preparation for clinical trials.
Among them, three companies, including Serum Institute (SII), which is conducting clinical trials of AstraZeneca vaccine, local pharmaceutical company Barat Biotech, and US pharmaceutical company Pfizer, have applied for urgent use of the vaccine to the Indian authorities.
PTI said it will take a little longer to approve the emergency use of the vaccine from Barat Biotech and Pfizer. In particular, it is reported that Pfizer has not conducted a presentation on approval of use to Indian authorities.
India plans to start vaccinating about 300 million people from next month when approval for emergency use of the vaccine is dropped.
Ten million people in the medical and health sector are the top priority targets for vaccination, and the vaccination will be expanded to 20 million people, including police, military personnel, and local government employees, as well as complications patients aged 50 or older and under 50.
SII has already finished producing 50 million doses in preparation for urgent approval. SII plans to produce 400 million doses of Corona 19 vaccine by next July.

In addition, India is tracking all those who have arrived from the UK in the last month to prevent the spread of the highly contagious variant Corona 19 in their country.
At present, in New Delhi, Telangana, Maharashtra, etc., dozens of infected people have recently been confirmed after entering the UK.
Two of these people, in particular, escaped from New Delhi’s quarantine facilities, went to their home provinces, and were arrested by the authorities.
Earlier, the British government implemented an emergency containment measure on the 19th as the corona19 variant virus spread rapidly in southeastern England including the capital London.
Meanwhile, according to the Ministry of Health and Family Welfare in India, the cumulative number of corona 19 confirmed cases in India on that day was 18,7,850, an increase of 18,732 from the previous day.
The world ranking for the cumulative number of confirmed cases is second only to the United States (1943 million, based on world ohms), but the spread has slowed significantly recently.
In September, the number of new confirmed cases per day reached 100,000. The number of confirmed cases per day on this day is the lowest in about 5 months since the beginning of July.

[email protected]
(End)

<저작권자(c) 연합뉴스, 무단 전재-재배포 금지>